Research Article

The Potential Role of Polymethyl Methacrylate as a New Packaging Material for the Implantable Medical Device in the Bladder

Table 2

The changes of inflammatory cytokines, IL-1β, IL-6, and TNF-α, in the bladder.

1 week 2 weeks 4 weeks

Control
 IL-1β (pg/mL)85.7 ± 0.0283.5 ± 0.0184.9 ± 0.01
 IL-6 (pg/mL) 253.8 ± 0.05 322.1 ± 0.01 302.9 ± 0.01
 TNF-α (pg/mL) 42.0 ± 0.0138.4 ± 0.0137.4 ± 0.02
Sham-operation
 IL-1β (pg/mL)84.0 ± 0.0285.3 ± 0.0386.0 ± 0.01
 IL-6 (pg/mL)249.3 ± 0.03 308.9 ± 0.01 311.7 ± 0.05
 TNF-α (pg/mL) 39.6 ± 0.0240.1 ± 0.0338.7 ± 0.01
PDMS-coating
 IL-1β (pg/mL)240.4 ± 0.01148.7 ± 0.02
 IL-6 (pg/mL) 515.7 ± 0.02 388.2 ± 0.03
 TNF-α (pg/mL) 70.5 ± 0.0147.2 ± 0.02
PMMA-coating
 IL-1β (pg/mL)189.7 ± 0.04150.1 ± 0.01
 IL-6 (pg/mL) 548.2 ± 0.01 389.4 ± 0.04
 TNF-α (pg/mL)62.8 ± 0.2348.5 ± 0.09

compared with the control, compared with sham-operation.